Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Hapten-Binding Bispecific Antibodies for the Targeted Delivery of SiRNA and SiRNA-Containing Nanoparticles.

Thorey IS, Grote M, Mayer K, Brinkmann U.

Methods Mol Biol. 2016;1364:219-34. doi: 10.1007/978-1-4939-3112-5_18.

PMID:
26472454
2.

Comparison of the lateral tail vein and the retro-orbital venous sinus routes of antibody administration in pharmacokinetic studies.

Schoch A, Thorey IS, Engert J, Winter G, Emrich T.

Lab Anim (NY). 2014 Mar;43(3):95-9. doi: 10.1038/laban.481.

PMID:
24552915
3.

Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases.

Flisikowska T, Thorey IS, Offner S, Ros F, Lifke V, Zeitler B, Rottmann O, Vincent A, Zhang L, Jenkins S, Niersbach H, Kind AJ, Gregory PD, Schnieke AE, Platzer J.

PLoS One. 2011;6(6):e21045. doi: 10.1371/journal.pone.0021045. Epub 2011 Jun 13.

4.
5.

MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes.

Vogl T, Ludwig S, Goebeler M, Strey A, Thorey IS, Reichelt R, Foell D, Gerke V, Manitz MP, Nacken W, Werner S, Sorg C, Roth J.

Blood. 2004 Dec 15;104(13):4260-8. Epub 2004 Aug 26.

PMID:
15331440
6.

Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis, and myofibroblast differentiation.

Thorey IS, Hinz B, Hoeflich A, Kaesler S, Bugnon P, Elmlinger M, Wanke R, Wolf E, Werner S.

J Biol Chem. 2004 Jun 18;279(25):26674-84. Epub 2004 Apr 7.

7.

Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.

Sterner-Kock A, Thorey IS, Koli K, Wempe F, Otte J, Bangsow T, Kuhlmeier K, Kirchner T, Jin S, Keski-Oja J, von Melchner H.

Genes Dev. 2002 Sep 1;16(17):2264-73.

8.

The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes.

Thorey IS, Roth J, Regenbogen J, Halle JP, Bittner M, Vogl T, Kaesler S, Bugnon P, Reitmaier B, Durka S, Graf A, Wöckner M, Rieger N, Konstantinow A, Wolf E, Goppelt A, Werner S.

J Biol Chem. 2001 Sep 21;276(38):35818-25. Epub 2001 Jul 19.

9.

Disruption of genes regulated during hematopoietic differentiation of mouse embryonic stem cells.

Muth K, Bruyns R, Thorey IS, von Melchner H.

Dev Dyn. 1998 Jun;212(2):277-83.

10.

Selective disruption of genes transiently induced in differentiating mouse embryonic stem cells by using gene trap mutagenesis and site-specific recombination.

Thorey IS, Muth K, Russ AP, Otte J, Reffelmann A, von Melchner H.

Mol Cell Biol. 1998 May;18(5):3081-8. Erratum in: Mol Cell Biol 1998 Oct;18(10):6164.

11.

Embryonic expression of human keratin 18 and K18-beta-galactosidase fusion genes in transgenic mice.

Thorey IS, Meneses JJ, Neznanov N, Kulesh DA, Pedersen RA, Oshima RG.

Dev Biol. 1993 Dec;160(2):519-34.

PMID:
7504637
12.

Alu sequence involvement in transcriptional insulation of the keratin 18 gene in transgenic mice.

Thorey IS, Ceceña G, Reynolds W, Oshima RG.

Mol Cell Biol. 1993 Nov;13(11):6742-51.

13.

Transcriptional insulation of the human keratin 18 gene in transgenic mice.

Neznanov N, Thorey IS, Ceceña G, Oshima RG.

Mol Cell Biol. 1993 Apr;13(4):2214-23.

14.

Parent-specific expression of a human keratin 18/beta-galactosidase fusion gene in transgenic mice.

Thorey IS, Pedersen RA, Linney E, Oshima RG.

Dev Dyn. 1992 Oct;195(2):100-12.

Supplemental Content

Loading ...
Support Center